FAQ
NanoSphere is for scientifically curious professionals and decision-makers working at the intersection of nanomedicine, biotechnology, gene therapy and advanced drug delivery.
Our ideal audience includes:
✔️ Researchers and scientists (PhDs, postdocs, lab heads) in academia and industry who want to stay on top of the latest trends in LNPs, mRNA, gene therapy, and targeted drug delivery.
✔️ Biotech founders and R&D leads looking to benchmark innovations, discover competitors, or find potential collaborators and emerging technologies.
✔️ Business development, regulatory, and medical affairs professionals seeking accessible, strategic insights without combing through dense academic papers.
✔️ Curators, science communicators, and educators who want sharp, well-curated summaries they can use in presentations, teaching, or reporting.
They come from academia, startups, mid-sized biotechs, CDMOs, or large pharmaceutical companies—often working in characterization, formulation development, regulatory affairs, business development, or clinical translation.
What unites them?
✔️ They’re overwhelmed by the volume of nanomedicine research and need smart, science-based curation to save time and focus on what matters
✔️ They want to sound credible and clear—whether explaining LNP mechanisms, formulation choices, or regulatory implications
✔️ They actively seek visibility and credibility—for themselves or their institutions—through expert interviews, co-branded content, or strategic co-posting
Whether they’re designing a breakthrough nanoparticle or scouting external innovation, NanoSphere helps them stay informed, elevate their work, and lead with clarity.
Our ideal audience includes:
✔️ Researchers and scientists (PhDs, postdocs, lab heads) in academia and industry who want to stay on top of the latest trends in LNPs, mRNA, gene therapy, and targeted drug delivery.
✔️ Biotech founders and R&D leads looking to benchmark innovations, discover competitors, or find potential collaborators and emerging technologies.
✔️ Business development, regulatory, and medical affairs professionals seeking accessible, strategic insights without combing through dense academic papers.
✔️ Curators, science communicators, and educators who want sharp, well-curated summaries they can use in presentations, teaching, or reporting.
They come from academia, startups, mid-sized biotechs, CDMOs, or large pharmaceutical companies—often working in characterization, formulation development, regulatory affairs, business development, or clinical translation.
What unites them?
✔️ They’re overwhelmed by the volume of nanomedicine research and need smart, science-based curation to save time and focus on what matters
✔️ They want to sound credible and clear—whether explaining LNP mechanisms, formulation choices, or regulatory implications
✔️ They actively seek visibility and credibility—for themselves or their institutions—through expert interviews, co-branded content, or strategic co-posting
Whether they’re designing a breakthrough nanoparticle or scouting external innovation, NanoSphere helps them stay informed, elevate their work, and lead with clarity.
Top 3 Frustrations in Nanomedicine
✔️ Information Overload: Navigating a Sea of Research
The field of nanomedicine is experiencing exponential growth. A bibliographic analysis revealed that from January 1999 to December 2022, there were 100,192 publications related to nanomedicine, with 80% published between 2015 and April 2023 . This translates to an average of approximately 6,000 publications per year, or about 500 per month. https://pmc.ncbi.nlm.nih.gov/articles/PMC10638504/?utm_source=chatgpt.com
Why is this a problem?
Time Constraints: Professionals have limited time to sift through vast amounts of literature to find relevant information.
Lack of Curation: Traditional databases and aggregators often lack the necessary filtering, leading to information overload.
✔️ Lack of Visibility: Innovations Going Unnoticed
Despite significant advancements, many researchers and startups struggle to gain visibility for their work. The competitive nature of high-impact journals and the limited reach of traditional publishing avenues mean that groundbreaking research can remain under the radar.
Why is this a problem?
Selective Publishing: Top journals have high rejection rates, making it challenging for innovative work to get published.
Limited Outreach: Startups and mid-sized companies often lack the resources for extensive marketing or PR campaigns.
✔️ Siloed Collaboration: Missed Opportunities Across Sectors
Collaboration between academia, industry, and regulatory bodies is crucial for the advancement of nanomedicine. However, these sectors often operate in silos, leading to missed opportunities for partnership and innovation.
Why is this a problem?
Communication Gaps: Differences in language, priorities, and timelines can hinder effective collaboration.
Lack of Platforms: There are few dedicated spaces where stakeholders from different sectors can connect and share insights.
How NanoSphere Addresses These Challenges
Curated Insights: NanoSphere offers expertly curated content, distilling complex research into accessible summaries, helping professionals stay informed without the overwhelm.
Enhanced Visibility: Through expert interviews, spotlight articles, and co-branded content, NanoSphere offers researchers and innovators a platform to amplify their work, increase visibility, and connect with key opinion leaders (KOLs).
Bridging Sectors: NanoSphere fosters cross-sector collaboration by connecting academia, industry, clinical, BD and regulatory bodies through shared knowledge and networking opportunities.
✔️ Information Overload: Navigating a Sea of Research
The field of nanomedicine is experiencing exponential growth. A bibliographic analysis revealed that from January 1999 to December 2022, there were 100,192 publications related to nanomedicine, with 80% published between 2015 and April 2023 . This translates to an average of approximately 6,000 publications per year, or about 500 per month. https://pmc.ncbi.nlm.nih.gov/articles/PMC10638504/?utm_source=chatgpt.com
Why is this a problem?
Time Constraints: Professionals have limited time to sift through vast amounts of literature to find relevant information.
Lack of Curation: Traditional databases and aggregators often lack the necessary filtering, leading to information overload.
✔️ Lack of Visibility: Innovations Going Unnoticed
Despite significant advancements, many researchers and startups struggle to gain visibility for their work. The competitive nature of high-impact journals and the limited reach of traditional publishing avenues mean that groundbreaking research can remain under the radar.
Why is this a problem?
Selective Publishing: Top journals have high rejection rates, making it challenging for innovative work to get published.
Limited Outreach: Startups and mid-sized companies often lack the resources for extensive marketing or PR campaigns.
✔️ Siloed Collaboration: Missed Opportunities Across Sectors
Collaboration between academia, industry, and regulatory bodies is crucial for the advancement of nanomedicine. However, these sectors often operate in silos, leading to missed opportunities for partnership and innovation.
Why is this a problem?
Communication Gaps: Differences in language, priorities, and timelines can hinder effective collaboration.
Lack of Platforms: There are few dedicated spaces where stakeholders from different sectors can connect and share insights.
How NanoSphere Addresses These Challenges
Curated Insights: NanoSphere offers expertly curated content, distilling complex research into accessible summaries, helping professionals stay informed without the overwhelm.
Enhanced Visibility: Through expert interviews, spotlight articles, and co-branded content, NanoSphere offers researchers and innovators a platform to amplify their work, increase visibility, and connect with key opinion leaders (KOLs).
Bridging Sectors: NanoSphere fosters cross-sector collaboration by connecting academia, industry, clinical, BD and regulatory bodies through shared knowledge and networking opportunities.
NanoSphere combines strengths of several channels while addressing their gaps. Unlike a journal, it’s accessible and fast-moving – you get the key points without wading through dense data. Unlike a generic news site or newsletter, it is laser-focused on nanomedicine and drug delivery, ensuring depth in that niche (readers won’t find cell therapy or general biotech news off-topic – every piece ties back to next-gen delivery sciences). The tone is neither overly technical nor oversimplified, striking a balance that speaks to PhDs and MBAs alike. NanoSphere’s format (regular blog articles plus an indexed website) allows searchability and continuous access to past content, which a fleeting email or feed doesn’t provide. Importantly, NanoSphere’s content is shaped by insiders in the field (scientists writing and curating for an audience of peers), giving it credibility and an informed voice, yet it’s presented in a polished, media-friendly way.
✔️ Led by scientists
NanoSphere is built and curated by scientists with deep expertise in nanomedicine, ensuring accuracy, relevance, and integrity behind every post.
✔️ Science-first, agenda-free
We don’t sell products. Our sole purpose is to spotlight meaningful innovation, not hype.
✔️ Cross-sector credibility
We collaborate with academic labs, biotech startups, CDMOs, and big pharma—offering balanced insights trusted by both science and industry.
✔️ Transparent and curated
No algorithms, no clickbait. Just hand-picked, well-explained updates backed by peer-reviewed research, regulatory releases, and expert interviews.
✔️ Recognized by peers
Our content is already followed by 2000+ professionals in pharma, academia, and biotech—including opinion leaders who trust us to tell their stories right.
NanoSphere is built and curated by scientists with deep expertise in nanomedicine, ensuring accuracy, relevance, and integrity behind every post.
✔️ Science-first, agenda-free
We don’t sell products. Our sole purpose is to spotlight meaningful innovation, not hype.
✔️ Cross-sector credibility
We collaborate with academic labs, biotech startups, CDMOs, and big pharma—offering balanced insights trusted by both science and industry.
✔️ Transparent and curated
No algorithms, no clickbait. Just hand-picked, well-explained updates backed by peer-reviewed research, regulatory releases, and expert interviews.
✔️ Recognized by peers
Our content is already followed by 2000+ professionals in pharma, academia, and biotech—including opinion leaders who trust us to tell their stories right.
NanoSphere is 100% free!
We believe nanomedicine knowledge should be accessible. All our content—interviews, blog posts, updates—is open to anyone, no subscription fees required.
(For sponsors and collaborators: premium visibility opportunities are available. Contact us for details.)
We believe nanomedicine knowledge should be accessible. All our content—interviews, blog posts, updates—is open to anyone, no subscription fees required.
(For sponsors and collaborators: premium visibility opportunities are available. Contact us for details.)
It’s simple. Just follow our LinkedIn — and that’s it.
From there, you’ll get everything in one place:
✔️ Daily scientific curation – hand-picked updates from the latest nanomedicine, mRNA, LNP, and drug delivery breakthroughs
✔️ Weekly interviews – insights from leading scientists, founders, and key opinion leaders in the field
✔️ Monthly articles – clear, accessible explainers on complex concepts and technologies
✔️ Monthly newsletter – a curated roundup of the most important developments across academia, industry, regulatory, clinical, and business landscapes
No signup forms. No paywalls. Just follow, scroll, and stay ahead.
From there, you’ll get everything in one place:
✔️ Daily scientific curation – hand-picked updates from the latest nanomedicine, mRNA, LNP, and drug delivery breakthroughs
✔️ Weekly interviews – insights from leading scientists, founders, and key opinion leaders in the field
✔️ Monthly articles – clear, accessible explainers on complex concepts and technologies
✔️ Monthly newsletter – a curated roundup of the most important developments across academia, industry, regulatory, clinical, and business landscapes
No signup forms. No paywalls. Just follow, scroll, and stay ahead.
Write us at info@nanosphere.blog or via our LinkedIn page.